Serlopitant ( DrugBank: Serlopitant )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
36表皮水疱症1

36. 表皮水疱症


臨床試験数 : 163 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03836001
(ClinicalTrials.gov)
April 18, 20197/2/2019A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis BullosaA Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis BullosaEpidermolysis BullosaDrug: Serlopitant Tablet;Drug: Placebo Oral TabletStanford UniversityEpidermolysis Bullosa Research Partnership;Menlo TherapeuticsActive, not recruiting13 YearsN/AAll29Phase 2United States